search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
85 new news items in the last 24 hours
  1. Home
  2. Economy

Novo Nordisk has appointed a new CEO, Maziar Mike Doustdar, and revised its financial estimates for 2023, forecasting a decline in sales.

Raluca Ioana Draghici
whatsapp
facebook
linkedin
x
copy-link copy-link
30 July 2025, 07:57
main event image
Economy
www.shutterstock.com
google-preference

Always see our news on Google

Danish pharmaceutical giant Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new CEO, replacing Lars Fruergaard Jørgensen. The company revised financial estimates, forecasting sales growth of between 8% and 14%, below previous expectations. The statement sent shares down 23%. The revision is due to weak expectations for sales of Wegovy and Ozempic drugs in the U.S. amid increased competition and use of compounded drugs. Doustdar, with over 30 years of experience in the company, promises to focus efforts on innovation and performance.

Sources

sursa imagine
Stiripesurse
Acţiunile Novo Nordisk s-au prăbuşit cu 23% după numirea unui nou CEO şi revizuirea negativă a estimărilor pentru 2025
sursa imagine
News.ro
Acţiunile Novo Nordisk s-au prăbuşit cu 23% după numirea unui nou CEO şi revizuirea negativă a estimărilor pentru 2025
sursa imagine
Ziarul Financiar
Bursă. Business internaţional. Scădere de 20% ieri pe acţiunile Novo Nordisk, cândva cea mai valoroasă companie europeană Grupul farmaceutic danez Novo Nordisk a anunţat marţi o revizuire în scădere a estimărilor de vânzări şi profit pentru 2025, din cauza încetinirii creşterii în Statele Unite...
sursa imagine
Profit.ro
Acțiunile Novo Nordisk s-au prăbușit

Latest News

13:26

Two 16-year-old teenagers died after the car they were in caught fire in Suceava County

13:14

Volodymyr Zelenskyy approved the retaliation plan proposed by the Security Service of Ukraine and the Army following the series of massive attacks launched by Russia against Ukrainian cities

13:00

Volodymyr Zelensky accuses Russia of attacking airports in Kyiv and Boryspil ahead of the US envoys’ visit

12:52

Botoşani: A man was detained for 24 hours after shooting a rabbit without having a hunting license

12:42

Aryna Sabalenka complained to the umpire about the smell of marijuana from the stands during her victory at the US Open

See more news

NEWS ON THE SAME TOPICS

event image
International
The CEO who laid off 900 employees before Christmas is outraged that he has now been fired in turn.
event image
Economy
BMW's sales have decreased by over 6%, reaching the lowest level in the last five years, after the company lowered its financial forecasts for 2026.
event image
International
Bill Pulte, appointed acting director of national intelligence services, intends to cut hundreds of positions within the ODNI.
event image
Economy
OMV reports a decrease in hydrocarbon production, but an increase in profit.
event image
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
event image
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
new nordisk negative estimates financial results fall in shares

Editor’s Recommendations

main event image
Opinions
Yesterday 10:01

Andrei Cornea: Călin Georgescu and Nicușor Dan - the enigmas of mass hypnosis

main event image
International
3 hours ago

AfD is the favorite in the elections in the state of Saxony-Anhalt, which will take place on Sunday

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
+5
main event image
International
4 hours ago

Donald Trump says that Vladimir Putin will not attack NATO: “I know him very well”

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol